Myriad expands hereditary cancer test to include additional genes
Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes cited in the …
Post
-
-
Real-time glucose tracking for better care
Continuous glucose monitors (CGMs) are small wearable medical devices that continuously measure glucose in the fluid under the skin and …
-
FDA clears Android version of Tandem Mobi mobile application
The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi …
-
Olympus lets 2,000 staff go in endoscopy restructuring initiative
Olympus has initiated a plan to restructure its endoscopy business, following numerous regulatory run-ins and controversy within the company’s leadership …
-
STAAR’s largest shareholder requests new directors in ongoing Alcon merger dispute
Broadwood Partners, the largest shareholder in STAAR Surgical, is calling on the company to enlist new directors to oversee the …
-
Meet Alleima at COMPAMED 2025
The world’s biggest trade show for the medical technology industry is right around the corner: COMPAMED 2025, running in parallel …
-
Snke unveils medical grade AR glasses to drive medtech industry adoption
Snke is preparing to launch SnkeXR, an open platform augmented reality (AR) headset specifically designed for the medtech industry. Snke, which …
-
Gore’s venous stent study meets primary endpoint
A report from WL Gore & Associates’ medical division has confirmed that a study of the GOREVIABAHN FORTEGRA venous stent for …
-
Exact Sciences reports outcomes from trial of HCC blood test
Exact Sciences has shared outcomes from the prospective ALTUS trial of its Oncoguard Liver blood test for identifying early-stage hepatocellular …
-
Organon divests JADA system to Laborie in $465m deal
Organon is selling its JADA post-partum haemorrhage (PPH) treatment system to Laborie Medical in a deal valued at up to …
-
Princess Margaret Cancer Centre and Helix launch genomics study in Canada
Princess Margaret Cancer Centre, part of Canada's University Health Network (UHN), has partnered with genomics company Helix to undertake the …
-
Nitinotes gains CE mark for endoscopic gastroplasty suturing platform
Israel-based Nitinotes Surgical has gained a CE mark for EndoZip, enabling the company to launch the automated suturing platform for …
-
Artivion treats first subject in trial of Arcevo LSA stent graft
Artivion has treated the first subject in the multi-centre ARTIZEN pivotal study to assess the Arcevo LSA hybrid stent graft …
-
How GLP-1 agonists impact US dialysis medical devices space
The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand …
-
Synchron secures $200m to advance Stentrode platform commercialisation
US-based Synchron has secured $200m in a Series D funding round to drive the commercial rollout of its Stentrode brain-computer …
